LABNOTESWeighed down with a torrent of information? We offer a sideways look at stories that caught the eye of Michael Kenward, our Editor at Large.
A formula for innovation?
The notion that you build and run racing cars for the benefit of today’s motorists is about as convincing as the idea that you send people to the Moon so that you can build a ...read more.
Is DBIS the DTI without energy?
At first sight, it looked like the effect of the UK government's latest reshuffle of departments was to reassemble the old Department of Trade and Industry. Just two years ago the DTI disappeared into the ...read more.
Students are revolting on knowledge transfer
While earlier generations of students took to the streets to protest about apartheid, miners' wages and even student fees, today's undergraduates, in the UK at least, seem to get hot under the collar about the ...read more.
More Labnotes
Labnotes RSS
THE INNOVATION ADVOCATERich Hudson looks across Europe for new policies, programmes and pronouncements aimed at improving the climate for innovation. Rich has been a leading science and technology journalist in Europe for 25 years, first with the Wall Street Journal and now with Science|Business.
Time for a Bretton Woods of innovation - A declaration
Sign the call for a Bretton Woods of Innovation Science|Business will be presenting this declaration calling for greater international collaboration in innovation policy to world leaders and global institutions - indeed, calling for a Bretton ...read more.
Time for a CTO in Brussels
For decades, the European Commission has toyed with ideas on how to make its leadership more tech-savvy. Now, with a Nobel-winning physicist as energy secretary in Washington, and a geologist as premier of China, the ...read more.
Innovative Medicines: 24 years from lab to market?
How long does it take to get a new medicine out of the lab and into the doctor's office? In Brussels, the answer to that question comes with a 2 billion euro price tag. A ...read more.
THE EARLY INVESTORMary Lisbeth D'Amico has been covering the early-stage scene in Europe since the dot.com era, first as a Senior Editor with Tornado Insider, then later as a freelance business journalist. Besides writing for Science|Business, Mary Lisbeth has also contributed to numerous publications including the Wall Street Journal Europe, Business Week, Red Herring, Real Deals, and the Journal of Life Sciences
German early-stage shows effect of economic slump
The economic crisis has finally hit home in the German early-stage market. But will Germany's cleantech industry bail out the flagging economy? In the first quarter of the year, German VCs roughly halfed the amount ...read more.
Target Partners sees opportunities in German-speaking market
In spite of the economic crisis, selected funds for early-stage investment are coming together in Europe. Following Index Venture's announcement in March of a new early-stage fund, British entrepreneurs Brent Hoberman (lastminute.com) and Michael Birch (bebo) have also announced formation of ...read more.
New Dutch fund focuses on energy efficiency
First time VC funds may be having a hard time drumming up money, but one Dutch investor is betting on spotting opportunities in energy technologies. Late last year Albert Fischer founded Yellow & Blue Clean Energy Investments BV, a fund dedicated to ...read more.
